A portion of amino acids 277-305 from the human protein was used as the immunogen for this IGFBP2 antibody.
IGFBP2-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors.